Elizabeth Crowley's Insider Trades & SAST Disclosures
Elizabeth Crowley's most recent trade in Celldex Therapeutics Inc. was a trade of 30,000 Common Stock done at an average price of $10.4 . Disclosure was reported to the exchange on June 14, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Elizabeth Crowley.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Celldex Therapeutics Inc. | Elizabeth Crowley | SR. VP & CPDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.38 per share. | 14 Jun 2024 | 30,000 | 39,074 (0%) | 0% | 10.4 | 311,400 | Common Stock |
| Celldex Therapeutics Inc. | Elizabeth Crowley | SR. VP & CPDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 30,000 | 46,500 | - | - | Incentive Stock Option (Right to Buy) | |
| Celldex Therapeutics Inc. | Elizabeth Crowley | SR. VP & CPDO | Sale of securities on an exchange or to another person at price $ 34.87 per share. | 14 Jun 2024 | 30,000 | 9,074 (0%) | 0% | 34.9 | 1,045,962 | Common Stock |
| Celldex Therapeutics Inc. | Elizabeth Crowley | SR. VP & CPDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 85,000 | 85,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Elizabeth Crowley | SR. VP & CPDO | Sale of securities on an exchange or to another person at price $ 35.06 per share. | 07 Jun 2024 | 15,000 | 9,074 (0%) | 0% | 35.1 | 525,873 | Common Stock |
| Celldex Therapeutics Inc. | Elizabeth Crowley | SR. VP & CPDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.02 per share. | 07 Jun 2024 | 7,500 | 24,074 (0%) | 0% | 9.0 | 67,624 | Common Stock |
| Celldex Therapeutics Inc. | Elizabeth Crowley | SR. VP & CPDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.38 per share. | 07 Jun 2024 | 7,500 | 16,574 (0%) | 0% | 10.4 | 77,850 | Common Stock |
| Celldex Therapeutics Inc. | Elizabeth Crowley | SR. VP & CPDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 7,500 | 0 | - | - | Incentive Stock Option (Right to Buy) | |
| Celldex Therapeutics Inc. | Elizabeth Crowley | SR. VP & CPDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 7,500 | 76,500 | - | - | Incentive Stock Option (Right to Buy) | |
| Celldex Therapeutics Inc. | Elizabeth Crowley | SR. VP & CPDO | Sale of securities on an exchange or to another person at price $ 33.64 per share. | 30 May 2024 | 38,597 | 9,074 (0%) | 0% | 33.6 | 1,298,384 | Common Stock |
| Celldex Therapeutics Inc. | Elizabeth Crowley | SR. VP & CPDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 34,445 | 0 | - | - | Incentive Stock Option (Right to Buy) | |
| Celldex Therapeutics Inc. | Elizabeth Crowley | SR. VP & CPDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.78 per share. | 30 May 2024 | 34,445 | 39,171 (0%) | 0% | 2.8 | 95,757 | Common Stock |
| Celldex Therapeutics Inc. | Elizabeth Crowley | SR. VP & CPDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.02 per share. | 30 May 2024 | 8,500 | 47,671 (0%) | 0% | 9.0 | 76,640 | Common Stock |
| Celldex Therapeutics Inc. | Elizabeth Crowley | SR. VP & CPDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2024 | 8,500 | 7,500 | - | - | Incentive Stock Option (Right to Buy) | |
| Celldex Therapeutics Inc. | Elizabeth Crowley | SR. VP &CPDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 80,000 | 80,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Elizabeth Crowley | SR. VP &CPDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 77,000 | 77,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Elizabeth Crowley | Sr. VP &CPDO | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 08 Dec 2021 | 4,000 | 4,726 (0%) | 0% | 40 | 160,000 | Common Stock |
| Celldex Therapeutics Inc. | Elizabeth Crowley | Sr. VP &CPDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2021 | 4,000 | 16,000 | - | - | Incentive Stock Option (Right to Buy) | |
| Celldex Therapeutics Inc. | Elizabeth Crowley | Sr. VP &CPDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.02 per share. | 08 Dec 2021 | 4,000 | 8,726 (0%) | 0% | 9.0 | 36,066 | Common Stock |
| Celldex Therapeutics Inc. | Elizabeth Crowley | Sr. VP &CPDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.78 per share. | 01 Nov 2021 | 8,555 | 9,043 (0%) | 0% | 2.8 | 23,783 | Common Stock |
| Celldex Therapeutics Inc. | Elizabeth Crowley | Sr. VP &CPDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 8,555 | 34,445 | - | - | Incentive Stock Option (Right to Buy) | |
| Celldex Therapeutics Inc. | Elizabeth Crowley | Sr. VP &CPDO | Sale of securities on an exchange or to another person at price $ 44.12 per share. | 01 Nov 2021 | 2,528 | 6,515 (0%) | 0% | 44.1 | 111,525 | Common Stock |
| Celldex Therapeutics Inc. | Elizabeth Crowley | Sr. VP &CPDO | Sale of securities on an exchange or to another person at price $ 41.62 per share. | 01 Nov 2021 | 1,189 | 4,726 (0%) | 0% | 41.6 | 49,481 | Common Stock |
| Celldex Therapeutics Inc. | Elizabeth Crowley | Sr. VP &CPDO | Sale of securities on an exchange or to another person at price $ 43.11 per share. | 01 Nov 2021 | 600 | 5,915 (0%) | 0% | 43.1 | 25,868 | Common Stock |
| Celldex Therapeutics Inc. | Elizabeth Crowley | Sr. VP &CPDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 58,000 | 58,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Elizabeth Crowley | Sr. VP &CPDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 84,000 | 84,000 | - | - | Incentive Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges